FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Exelon 9.5mg/24hours transdermal patches (Waymade Healthcare Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Waymade Healthcare Plc) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Waymade Healthcare Plc) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Lexon (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches 15 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Necessity Supplies Ltd) 15 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Necessity Supplies Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches 15 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Necessity Supplies Ltd) 15 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Necessity Supplies Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Necessity Supplies Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Necessity Supplies Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Doncaster Pharmaceuticals Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Doncaster Pharmaceuticals Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Doncaster Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Mawdsley-Brooks & Company Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 12micrograms/hour transdermal patches (Luye Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 25micrograms/hour transdermal patches (Luye Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 50micrograms/hour transdermal patches (Luye Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 75micrograms/hour transdermal patches (Luye Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 100micrograms/hour transdermal patches (Luye Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 12micrograms/hour transdermal patches (Luye Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 25micrograms/hour transdermal patches (Luye Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 50micrograms/hour transdermal patches (Luye Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 75micrograms/hour transdermal patches (Luye Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 100micrograms/hour transdermal patches (Luye Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 14 of 21 Next End

This concept is not in any reference sets

Back to Start